zelebrudomide
Generic: Zelebrudomide
zelebrudomide: 1 clinical trial tracked.
zelebrudomide evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about zelebrudomide, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase 1, Dose Escalation, Safety and Tolerability Study of NX-2127, a Bruton's Tyrosine Kinase (BTK) Degrader, in Adults With Relapsed/Refractory B-cell Malignancies
Primary endpoint: Number of Participants with Protocol Specified Dose-Limiting Toxicities
Interventionalopen248 targetStarted 2021-05Completion 2027-0516 sites · United StatesNurix Therapeutics, Inc.